Literature DB >> 15553711

[Case report on intra-tumor injection therapy of dendritic cells in advanced gastric cancer].

Masashi Kanazawa1, Kazue Yoshihara, Hiroyuki Abe, Manabu Iwadate, Kumiko Watanabe, Satoshi Suzuki, Yoshiyuki Endoh, Shinnji Ohki, Ken-ichi Takita, Kouji Sekikawa, Seiichi Takenoshita, Tadayuki Takagi, Atsushi Irisawa, Yukio Sato, Takashi Ogata, Hitoshi Ohto.   

Abstract

Dendritic cells (DC) are powerful antigen-presenting cells, and have attracted attention in recent years from the viewpoint of DC vaccine therapy against cancer. However, the existence of an immunosuppressive state in cancer individuals leads to anergy and failure in cytotoxic T cell (CTL) induction and DC migration to the target organ. It has been reported that injected intra-tumor DCs are expected to work phagocytosis of the tumor as a localized effect. Consequently CTL induction in the tumor and the regional lymphnodes results in a systemic effect. In this study, intra-tumor DC injection therapy was performed by means of endoscopic ultrasonography (EUS) in 2 gastric cancer cases. As a result, tumor markers and ascites of one case were on the decrease. The results indicate this method can be useful in advanced cancer patients.

Entities:  

Mesh:

Year:  2004        PMID: 15553711

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

Review 1.  Endoscopic ultrasound-fine needle injection for oncological therapy.

Authors:  Jeremy Kaplan; Amaara Khalid; Natalie Cosgrove; Ayesha Soomro; Syed Mohsin Mazhar; Ali A Siddiqui
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

2.  Therapeutic effect of intratumoral injections of dendritic cells for locally recurrent gastric cancer: a case report.

Authors:  Masanori Kobayashi; Tomoyo Sakabe; Asako Chiba; Akihito Nakajima; Masato Okamoto; Shigetaka Shimodaira; Yoshikazu Yonemitsu; Yuta Shibamoto; Noboru Suzuki; Masaki Nagaya
Journal:  World J Surg Oncol       Date:  2014-12-19       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.